Live Breaking News & Updates on Targeted Therapeutic Delivery

Stay updated with breaking news from Targeted therapeutic delivery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

C4 Therapeutics : CTOS 2023 - CFT8634 Phase 1 Dose Escalation -November 01, 2023 at 07:19 am EDT

Initial Results From A Phase 1 Study of CFT8634, A Novel Bifunctional Degradation Activating Compound of BRD9, in Synovial Sarcoma and SMARCB1-Null Tumors

. ....

Ammax Bio , Daiihi Sankyo , Daiichi Sankyo , Eli Lilly , Jazz Pharmaceuticals , Sarcoma Alliance For Research , Ayala Pharmaceuticals , Therapeutics Inc , Certis Oncology Solutions , Salarius Pharmaceuticals , Threshold Pharmaceuticals , Health Advances , Kowa Research Institute , Humans In Health , Research To Practice , Desmoid Tumor Research Foundation , Theseus Pharmaceuticals , Boehringer Ingelheim , Novo Holdings , Eastern Cooperative Oncology Group , Servier Pharmaceuticals , Common Terminology Criteria , Adverse Events , Positron Emission Tomography , Computed Tomography , Response Evaluation Criteria ,